BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30471109)

  • 1. LncRNA miR143HG suppresses bladder cancer development through inactivating Wnt/β-catenin pathway by modulating miR-1275/AXIN2 axis.
    Xie H; Huang H; Huang W; Xie Z; Yang Y; Wang F
    J Cell Physiol; 2019 Jul; 234(7):11156-11164. PubMed ID: 30471109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
    Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
    J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.
    Zhang Q; Miao S; Han X; Li C; Zhang M; Cui K; Xiong T; Chen Z; Wang C; Xu H
    Cell Death Dis; 2018 Sep; 9(10):960. PubMed ID: 30237499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA GAS5 regulates the Wnt/β-catenin pathway through the miR-18a-5p/AXIN2/GSK3β axis to inhibit the proliferation and migration of bladder cancer cells.
    Zhang Z; Liu T; Cheng C; Wang J; Wang C; Huang H; Li Y
    Carcinogenesis; 2022 Dec; 43(12):1176-1189. PubMed ID: 36331809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA DANCR Activates Wnt/β-Catenin Signaling through MiR-216a Inhibition in Non-Small Cell Lung Cancer.
    Yu JE; Ju JA; Musacchio N; Mathias TJ; Vitolo MI
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior 
of Lung Squamous Cell Carcinoma H520 Cells].
    Gou L; He Y; Qiu P; Huang B
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/AXIN2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical Cancer.
    Niu Z; Wang F; Lv S; Lv Y; Liu M; Fu L; Yao Y; Wang L; Lin W; Yuan F
    Mol Cell Biol; 2021 Sep; 41(10):e0011521. PubMed ID: 34309414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.
    Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
    Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
    Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
    Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2.
    Chen D; Li SG; Chen JY; Xiao M
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4828-4836. PubMed ID: 30070321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2.
    Chen HY; Lang YD; Lin HN; Liu YR; Liao CC; Nana AW; Yen Y; Chen RH
    Sci Rep; 2019 Jul; 9(1):9687. PubMed ID: 31273221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
    Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
    J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.
    Li J; Li Y; Meng F; Fu L; Kong C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling.
    Tian H; Wang X; Lu J; Tian W; Chen P
    Chem Biol Interact; 2019 Aug; 308():244-251. PubMed ID: 31145890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.